Digital Sleep Program for College Students with Insomnia

Last updated: February 24, 2025
Sponsor: Taipei Medical University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Insomnia

Treatment

Waitlist control group

digital-based multimodal sleep management program

Clinical Study ID

NCT06853106
N202401041
  • Ages 18-26
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of a digital-based multimodal sleep management program compared to a waitlist control group in improving sleep-related outcomes, including insomnia severity, daytime sleepiness, objective sleep parameters, and sleep reactivity to stress, as well as psychological health indices, such as depression, anxiety, and resilience. Additionally, this study seeks to examine the mediating role of different chronotypes in the effectiveness of the sleep intervention on the outcomes of interest.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Registered as a full-time student

  2. Aged 18 to 26 years old

  3. Experiencing insomnia for at least three months

  4. Currently own and use a personal mobile device

  5. Ability to read and speak Chinese

  6. Not taking hypnotics, sedatives, or antidepressants

  7. Not pregnant or lactating

Exclusion

Exclusion Criteria:

  1. Using a smartphone model that cannot support the app

  2. Currently using other sleep program apps

  3. Meeting a STOP-BANG score of ≥3

Study Design

Total Participants: 90
Treatment Group(s): 2
Primary Treatment: Waitlist control group
Phase:
Study Start date:
April 24, 2024
Estimated Completion Date:
July 31, 2027

Study Description

This is a parallel-group, randomized controlled trial (RCT). 90 participants who experiencing insomnia for at least 3 months with college students will be enrolled.

Eligible participants who complete the baseline measurements will be randomly allocated to a digital-based multimodal sleep management program group (N = 45) and a waitlist control group (N = 45).

The primary outcome is insomnia severity, assessed using the Insomnia Severity Index (ISI). The secondary outcomes include daytime sleepiness, objective sleep parameters, sleep reactivity, resilience, anxiety, and depression, which will be examined using the Epworth Sleepiness Scale (ESS), a wearable sleep tracker, the Ford Insomnia Response to Stress Test (FIRST), the Brief Resilience Scale (BRS), the State-Trait Anxiety Inventory (STAI), and the Beck Depression Index II (BDI-II), respectively. Additionally, chronotype will be assessed using the Morningness-Eveningness Questionnaire (MEQ) as a moderating role to be tested in this study. All outcomes will be measured at three time points: T0 (baseline assessment), T1 (immediately after the 4-week intervention period), and T2 (4 weeks after the intervention period).

Connect with a study center

  • Taipei Medicine University

    Taipei, 11031
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.